AtriCure Inc
NASDAQ:ATRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AtriCure Inc
NASDAQ:ATRC
|
US |
|
Nissan Chemical Corp
TSE:4021
|
JP |
|
Gaumont SA
PAR:GAM
|
FR |
|
PPL Corp
NYSE:PPL
|
US |
|
S
|
SPCG PCL
SET:SPCG
|
TH |
|
COSCO SHIPPING Development Co Ltd
OTC:CITAF
|
CN |
|
P
|
Peyto Exploration & Development Corp
F:PXK
|
CA |
|
A
|
Arad Ltd
TASE:ARD
|
IL |
|
C
|
CrowdStrike Holdings Inc
F:45C
|
US |
Intrinsic Value
Is ATRC undervalued or overvalued?
See the intrinsic value estimate for
AtriCure Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ATRC looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ATRC’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What AtriCure Does
AtriCure makes medical devices used by heart surgeons to treat atrial fibrillation and related heart rhythm problems. Its products include surgical ablation tools that create controlled scar lines in the heart tissue, plus systems used to remove or close off the left atrial appendage, a part of the heart linked to stroke risk in some patients. The company sells mainly to hospitals and cardiac surgery teams.
- Headquarters
- United States of America US
- Employees
- 1 350
- IPO date
- Aug 5, 2005
Revenue & Expenses Breakdown
AtriCure Inc
Earnings Waterfall
AtriCure Inc
The intrinsic value for
AtriCure Inc (ATRC) under the Base Case is hidden USD.
Compared with the current market price of 61.08 USD, the stock appears hidden.